Guideline 63 - Supporting Material

	Guideline topic: Pharmacological management of asthma Evidence table 4.1: Inhaled short acting beta 2 agonists
Author		Year	Study type	Quality rating	Population	Outomes measured	Effect size	Confidence intervals / p values	Comments
Adults
Dennis S et al¹		2000	RCT	++	Adult asthmatics with mild disease	Exacerbation rate, symptoms, PEF, b 2 agonist use	No difference in exacerbation rate	Yes	Results in agreement with Cochrane review.
Walters & Walters²		2000	Cochrane review	++

Dennis SM, Sharp SJ, Vickers MR, Frost CD, Crompton GK, Barnes PJ, et al. Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework. Lancet 2000;355(9216):1675-9.
Walters EH, Walters J. Inhaled short acting beta2-agonist use in asthma: regular versus as needed treatment (Cochrane Review). In: The Cochrane Library, Issue 3, 2001. Oxford: Update Software.